Physician profile
Eugene E Curry
NPI 1710992110
$3,110,088.11
in general payments reported to CMS, 2019-2025
10 companies · $740K in 2025
The $740K reported for 2025 was more than what 99% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176K · 2020: $236K · 2021: $354K · 2022: $351K · 2023: $380K · 2024: $873K · 2025: $740K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.0M · Consulting Fee: $30K · Travel and Lodging: $3,953 · Food and Beverage: $1,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,958,090.47 |
| Consulting Fee | $29,787.50 |
| Travel and Lodging | $3,953.22 |
| Food and Beverage | $1,316.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,063,814.58 | 2019-2025 | Arthrex |
| Stryker Corporation | $43,542.39 | 2021-2025 | Ezout, Stryker F1, Remb |
| Pylant Medical | $2,463.62 | 2019-2025 | |
| Medline Industries Lp | $61.16 | 2024 | |
| Horizon Therapeutics Plc | $47.70 | 2019 | |
| Wright Medical Technology, INC. | $47.30 | 2019-2020 | |
| Orthofix Medical, INC. | $36.18 | 2019 | |
| Ferring Pharmaceuticals INC. | $35.83 | 2021-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $24.22 | 2021 | |
| Ossur Americas, INC. | $15.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Curry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.